Trump struck deals with 16 drug companies. They're still raising prices : NPR
NPR • • general
Key Points:
- Sixteen major drug companies that made "most favored nation" deals with the Trump administration to lower drug prices still raised list prices on 872 brand-name drugs in early 2026, including treatments for cancer, heart failure, diabetes, and some COVID vaccines.
- The median price increase was 4%, consistent with previous years, despite the administration's claims that these deals would lower prices for American consumers while increasing prices in other wealthy countries.
- The White House downplayed the significance of list price hikes, emphasizing that discounts from the deals benefit Medicaid programs and cash-paying patients, but experts say the agreements have minimal impact on prices paid by most insured Americans.
- Some drugs, particularly those subject to Medicare price negotiations under the Inflation Reduction Act, saw
 { path { fill: %23EEEFE9 } })